HealthcareServices

Oligonucleotide Synthesis Services Market Forecast: How Big Will It Be by 2030?

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oligonucleotide synthesis services market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Oligonucleotide Synthesis Services Market from 2026 to 2030?

In recent years, the oligonucleotide synthesis services market size has demonstrated substantial growth. It is projected to expand from $2.93 billion in 2025 to $3.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. The historical growth of this market can be attributed to the increased utilization of PCR and sequencing, the expansion of molecular biology research, a rise in genomic testing, an increase in academic genomics funding, and the broadening of biotech R&D activities.

The market for oligonucleotide synthesis services anticipates substantial expansion over the upcoming years. By 2030, this market is projected to reach a valuation of $4.7 billion, demonstrating a compound annual growth rate (CAGR) of 10.0%. Key drivers for this projected growth include the expanding pipelines for gene and cell therapies, the increasing need for CRISPR and gene editing technologies, the proliferation of nucleic acid therapeutics, a greater adoption of precision diagnostics, and the increased production scale for clinical oligonucleotides. Significant trends expected during this forecast timeframe encompass high-throughput production of custom oligos, services for modified and labeled oligonucleotides, GMP-grade oligo manufacturing, quick-turnaround gene editing oligos, and sophisticated oligonucleotide purification workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33245&type=smp

What Drivers Are Affecting Demand In The Oligonucleotide Synthesis Services Market?

A rising emphasis on personalized medicine is projected to stimulate the expansion of the oligonucleotide synthesis services market in the future. This medical strategy involves tailoring treatment and prevention plans according to an individual’s unique genetic makeup, biological factors, and lifestyle traits. Its growing acceptance stems from breakthroughs in genomics and molecular diagnostics, enabling the customization of therapies to an individual’s genetic profile for improved results. These services facilitate personalized medicine through the quick and accurate creation of bespoke DNA or RNA sequences, which are vital for patient-specific diagnostics, targeted therapies, and gene-based treatments, thereby allowing interventions to be customized to an individual’s genetic blueprint. As an illustration, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that in 2023, the FDA sanctioned 16 novel personalized therapies for patients with rare diseases, an increase from six approvals in 2022. Among the newly approved personalized treatments for 2023 were also seven cancer medications and three for various other ailments and conditions. Consequently, the heightened emphasis on personalized medicine is propelling the expansion of the oligonucleotide synthesis services market.

Which Segment Groups Are Influencing The Oligonucleotide Synthesis Services Market?

The oligonucleotide synthesis services market covered in this report is segmented –

1) By Type Of Oligonucleotide: Deoxyribonucleic Acid Oligonucleotides; Ribonucleic Acid Oligonucleotides; Peptide Nucleic Acids (PNAs); Locked Nucleic Acids (LNAs); Other Synthetic Nucleotides

2) By Synthesis Method: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Oligonucleotide Synthesis Via Automated Synthesizers; Enzymatic Synthesis

3) By Purity Level: Standard Purity; High Purity; Ultra High Purity; Custom Purity Solutions; Quality Control Measures

4) By Application: Diagnostics; Therapeutics; Research And Development; Gene Editing; Vaccine Development

5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Contract Research Organizations (CROs); Clinical Laboratories

Subsegments:

1) By Deoxyribonucleic Acid Oligonucleotides: Standard Deoxyribonucleic Acid Oligonucleotides; Modified Deoxyribonucleic Acid Oligonucleotides; Phosphorothioate Deoxyribonucleic Acid Oligonucleotides; Methylated Deoxyribonucleic Acid Oligonucleotides

2) By Ribonucleic Acid Oligonucleotides: Standard Ribonucleic Acid Oligonucleotides; Modified Ribonucleic Acid Oligonucleotides; Small Interfering Ribonucleic Acid Oligonucleotides; Micro Ribonucleic Acid Oligonucleotides

3) By Peptide Nucleic Acids: Standard Peptide Nucleic Acids; Modified Peptide Nucleic Acids; Functionalized Peptide Nucleic Acids

4) By Locked Nucleic Acids: Standard Locked Nucleic Acids; 2′-O-Methyl Locked Nucleic Acids; Gapmer Locked Nucleic Acids

5) By Other Synthetic Nucleotides: Morpholino Oligonucleotides; Phosphoramidite Oligonucleotides; Xeno Nucleic Acid Oligonucleotides; Synthetic Aptamers

What Long-Term Trends Are Expected To Shape The Future Of The Oligonucleotide Synthesis Services Market?

Leading firms within the oligonucleotide synthesis services market are concentrating on enhancing their DNA and RNA manufacturing capacities to aid therapeutic and diagnostic investigations. These capabilities encompass sophisticated techniques for generating and expanding premium genetic material, which are essential for facilitating scientific inquiry, diagnostic procedures, and the creation of biopharmaceutical treatments. As an illustration, in May 2025, Oligo Factory Inc., a manufacturing enterprise based in the US, introduced a low-volume oligo synthesis service to extend its assistance to those involved in therapeutic and diagnostic research and development. This service facilitates the bespoke production of DNA/RNA in small quantities, beginning at 50 nmol, suitable for initial research and development phases in areas such as therapeutics, diagnostics, qPCR, NGS, and preclinical studies. It reduces expenditures and minimizes waste, provides rapid delivery (in 4 weeks or less) adhering to GMP or ISO 13485 quality standards, and allows for effortless scaling through portfolios like FactorTx, eliminating the need for supplier transitions. This flexibility is advantageous for researchers who require prototypes rather than large minimum orders.

Who Are The Prominent Global Companies Shaping The Oligonucleotide Synthesis Services Market Landscape?

Major companies operating in the oligonucleotide synthesis services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Sangon Biotech (Shanghai) Co. Ltd., Ajinomoto Co. Inc., Twist Bioscience Corporation, Sigma-Aldrich Co. LLC, Aldevron LLC, Bioneer Corporation, GenScript Biotech Corporation, BBI Life Sciences Ltd., Takara Bio Inc., BioServe Biotechnologies Ltd., Eurofins Genomics Germany GmbH, Bio-Synthesis Inc., TriLink BioTechnologies LLC, BioBasic Inc., Biosearch Technologies Inc., JenaBioscience GmbH, Geneworks Pty Ltd., HUWEL Life Science Co. Ltd., and SynoLigo Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-services-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Oligonucleotide Synthesis Services Market?

North America was the largest region in the oligonucleotide synthesis services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oligonucleotide Synthesis Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33245&type=smp

Browse Through More Reports Similar to the Global Oligonucleotide Synthesis Services Market 2026, By The Business Research Company

Oligonucleotide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotide-synthesis-global-market-report

Oligonucleotides Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-supply-chain-or-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795